| Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial AK Davis, FS Barrett, DG May, MP Cosimano, ND Sepeda, MW Johnson, ... JAMA Psychiatry 78 (5), 481-489, 2021 | 907 | 2021 |
| Emotions and brain function are altered up to one month after a single high dose of psilocybin FS Barrett, MK Doss, ND Sepeda, JJ Pekar, RR Griffiths Scientific reports 10 (1), 2214, 2020 | 249 | 2020 |
| Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up N Gukasyan, AK Davis, FS Barrett, MP Cosimano, ND Sepeda, ... Journal of Psychopharmacology 36 (2), 151-158, 2022 | 214 | 2022 |
| Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder MK Doss, M Považan, MD Rosenberg, ND Sepeda, AK Davis, PH Finan, ... Translational psychiatry 11 (1), 574, 2021 | 153 | 2021 |
| People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences MT Williams, AK Davis, Y Xin, ND Sepeda, PC Grigas, S Sinnott, ... Drugs: Education, Prevention and Policy 28 (3), 215-226, 2021 | 97 | 2021 |
| Psychedelic treatment for trauma-related psychological and cognitive impairment among US special operations forces veterans AK Davis, LA Averill, ND Sepeda, JP Barsuglia, T Amoroso Chronic Stress 4, 2470547020939564, 2020 | 62 | 2020 |
| Increases in psychological flexibility mediate relationship between acute psychedelic effects and decreases in racial trauma symptoms among people of color AK Davis, Y Xin, ND Sepeda, A Garcia-Romeu, MT Williams Chronic Stress 5, 24705470211035607, 2021 | 28 | 2021 |
| Inhaled 5-methoxy-N, N-dimethyltryptamine: supportive context associated with positive acute and enduring effects ND Sepeda, JM Clifton, LY Doyle, R Lancelotta, RR Griffiths, AK Davis Journal of Psychedelic Studies 4 (2), 114-122, 2020 | 20 | 2020 |
| Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey SM Nayak, H Jackson, ND Sepeda, DS Mathai, S So, A Yaffe, H Zaki, ... Frontiers in Psychiatry 14, 1199642, 2023 | 8 | 2023 |
| Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans SB Armstrong, Y Xin, ND Sepeda, M Polanco, LA Averill, AK Davis Military psychology 36 (2), 184-191, 2024 | 6 | 2024 |
| Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in … AK Davis, Y Xin, N Sepeda, LA Averill The American Journal of Drug and Alcohol Abuse 49 (5), 587-596, 2023 | 3 | 2023 |
| Predictors of psychedelic treatment outcomes among special operations forces veterans. Y Xin, SB Armstrong, LA Averill, N Sepeda, AK Davis Psychology of Consciousness: Theory, Research, and Practice, 2023 | 2 | 2023 |
| Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use DS Mathai, DE Roberts, SM Nayak, ND Sepeda, A Lehrner, M Johnson, ... PsyArXiv, 2023 | 1 | 2023 |
| The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial … AW Levin, R Lancelotta, ND Sepeda, N Gukasyan, S Nayak, TL Wagener, ... PloS one 19 (3), e0300501, 2024 | | 2024 |
| Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers DS Mathai, S Hilbert, ND Sepeda, JC Strickland, RR Griffiths, ... Psychedelic Medicine 1 (4), 241-252, 2023 | | 2023 |
| Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences AK Davis, C Timmermann, AM Ortiz Bernal, R Lancelotta, S Nayak, ... Journal of psychoactive drugs, 1-11, 2023 | | 2023 |
Alan K. DavisThe Ohio State UniversityAdresse e-mail validée de osu.edu
